On June 10, the Black Directors Health Equity Agenda (BDHEA) convened board directors, executives, healthcare leaders, clinicians, policymakers, and community partners for its 2026 Virtual Town Hall, focused on advancing health equity and improving outcomes in Black and marginalized communities.

Town Hall Speakers included Caretha Coleman, Executive Sponsor and Board Chair of BDHEA; Deborah Phillips, Executive Director of BDHEA; Linda Goler Blount, MPH, President and CEO of Community Catalyst and member of the BDHEA Clinical Steering Council; Yolanda Lawson, MD, former President of the National Medical Association and member of the BDHEA Steering Council; and Sana Imam, Playbook Program Manager at BDHEA. BDHEA leaders highlighted key initiatives, including a new Direct Relief-funded maternal and infant health pilot, the forthcoming Health Equity Playbook, and plans for the 2027 BDHEA National Summit.

The Town Hall concluded with a discussion of the evolving federal 340B Drug Pricing Program and its implications for patient access, safety-net providers, and health equity, sponsored by the Pfizer Multicultural Health Equity Collective. Presenters included Allison Grannis, Director, Head of US State Policy at Pfizer, and Thomas Johnson, Executive Director of ASAP 340B.

For a Town Hall summary, including key takeaways and ways to get involved, click here.

340B Session